SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DECODE GENETICS-*DCGN
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (191)5/24/2005 10:23:59 AM
From: carranza2   of 313
 
I have given a lot of thought to the way the MI drug was "found."

It may very well be a completely new way of doing things. Wonder if any IPR issues are involved?

The way the MI drug was "discovered" potentially opens up a whole new source of income for DCGN if it can keep the method proprietary.

Clever bastards.

Even if it cannot patent the method, as a pioneer it will have a lot of interested pharmas knocking at its door and therefore is likely to gain new sources of income.

Based on this, I have added to my position today though I hate to pay these prices.

Edit: I briefly, very briefly, reviewed DCGN's patents and patent applications. Didn't see anything that dealt specifically with the method I think was used with respect to the MI drug, though there are a number of software patents and applications which might fit the bill. This area is really not one in which I feel competent to comment upon. Perhaps others will join in.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News